This inventor holds 1 USPTO granted patent. Top assignee: Denka Seiken Co., Ltd.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Kenichi Takasugi: Innovator in Cholesterol Quantification
Introduction
Kenichi Takasugi is a notable inventor based in Goshen, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the quantification of cholesterol.
Latest Patents
Takasugi holds a patent for a method that quantifies cholesterol present in low-density lipoproteins (LDL). This innovative method allows for the separate quantification of LDL cholesterol without the need for complicated centrifuge operations. The process involves a first step of erasing cholesterol in high-density lipoprotein, very low-density lipoprotein, and chylomicron in a test sample. The second step quantifies the cholesterol that remains in the test sample.
Career Highlights
Kenichi Takasugi is associated with Denka Seiken Co., Ltd., a company known for its advancements in medical technology. His work has contributed to improving cholesterol testing methods, which are crucial for cardiovascular health assessments.
Collaborations
Takasugi has collaborated with notable colleagues, including Hiroshi Matsui and Kazushige Mizuno, to further enhance the effectiveness of his innovations.
Conclusion
Kenichi Takasugi's contributions to cholesterol quantification represent a significant advancement in medical diagnostics. His innovative methods simplify the testing process, making it more accessible and efficient for healthcare providers.